Copper-catalyzed cascade reactions between alkenes or alkynes and diaryliodonium salts form carbocyclic products in a single step. Arylation of the unsaturated functional group is proposed to form a carbocation intermediate that facilitates hydride shift pathways to translocate the positive charge to a remote position and enables ring formation via a Friedel-Crafts-type reaction.
Copper-catalyzed arylation of electron rich alkynes reveals stabilized trisubstituted vinyl cation equivalents that react with pendant arene nucleophiles to form all carbon tetrasubstituted alkenes. The new process streamlines the synthesis of important medicinally relevant molecules.
A general procedure for the copper-catalyzed regioselective
ring-opening of epoxides with Grignard reagents is described. The
procedure developed provides robust reaction conditions which limit
the formation of impurities and has been applied successfully using
a series of epoxides and Grignard reagents to provide the desired
products in >90% yield with excellent regioselectivity and purity.
The reaction of alkyl instead of aryl substituted alkynes with (II) under the investigated conditions does not give the corresponding alkyl substituted cyclopentenes. The conversion of an enantiomerically enriched aryl alkyne proceeds with minimal erosion of the enantiomeric excess. Compound (XIX) is further transformed to the retinoid receptor agonist BMS-189453 (XX) offering a significantly shorter synthetic route to this drug compared to previously developed ways. -(ZHANG, F.; DAS, S.; WALKINSHAW, A. J.; CASITAS, A.; TAYLOR, M.; SUERO, M. G.; GAUNT*, M. J.; J. Am. Chem. Soc. 136 (2014) 25, 8851-8854, http://dx.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.